1. Tannic Acid Provides Neuroprotective Effects Against Traumatic Brain Injury Through the PGC-1α/Nrf2/HO-1 Pathway
   Mohd. Salman et al, 2020, Molecular Neurobiology CrossRef
2. Edaravone mitigates hemorrhagic cystitis by modulating Nrf2, TLR‐4/NF‐κB, and JAK1/STAT3 signaling in cyclophosphamide‐intoxicated rats
   Emad H. M. Hassanein et al, 2021, Journal of Biochemical and Molecular Toxicology CrossRef
3. Edaravone Attenuates Disease Severity of Experimental Auto-Immune Encephalomyelitis and Increases Gene Expression of Nrf2 and HO-1
   D MICHALIČKOVÁ et al, 2022, Physiological Research CrossRef
4. Potential Therapies for Cerebral Edema After Ischemic Stroke: A Mini Review
   Yi Yao et al, 2021, Frontiers in Aging Neuroscience CrossRef
5. MicroRNAs Involved in Oxidative Stress Processes Regulating Physiological and Pathological Responses
   Yongjie Xu et al, 2021, MicroRNA CrossRef
6. Chinese Herbal Preparation SaiLuoTong Alleviates Brain Ischemia via Nrf2 Antioxidation Pathway–Dependent Cerebral Microvascular Protection
   Xiao-Di Fan et al, 2021, Frontiers in Pharmacology CrossRef
7. Edaravone ameliorates depressive and anxiety-like behaviors via Sirt1/Nrf2/HO-1/Gpx4 pathway
   Ruozhi Dang et al, 2022, Journal of Neuroinflammation CrossRef
8. Cerebral edema after ischemic stroke: Pathophysiology and underlying mechanisms
   Yuhang Gu et al, 2022, Frontiers in Neuroscience CrossRef
9. Effects of the Edaravone, a Drug Approved for the Treatment of Amyotrophic Lateral Sclerosis, on Mitochondrial Function and Neuroprotection
   Sun Joo Cha et al, 2022, Antioxidants CrossRef
10. Effect of microbubbles on transcranial doppler ultrasound-assisted intracranial recombinant tissue-type plasminogen activator thrombolysis
    Wei-Song Liu et al, 2023, Vascular CrossRef
11. Therapeutic effects of a standardized-flavonoid Diospyros kaki L.f. leaf extract on transient focal cerebral ischemia-induced brain injury in mice
    Loan Thanh Thi Nguyen et al, 2023, Journal of Natural Medicines CrossRef
12. Edaravone Plays Protective Effects on LPS-Induced Microglia by Switching M1/M2 Phenotypes and Regulating NLRP3 Inflammasome Activation
    Jiping Li et al, 2021, Frontiers in Pharmacology CrossRef
13. Editorial: Neuroprotection and Disease Modification in Parkinson’s Disease
    Matilde Otero-Losada et al, 2021, Frontiers in Pharmacology CrossRef
14. Role of Edaravone as a Treatment Option for Patients with Amyotrophic Lateral Sclerosis
    HaEun Cho et al, 2020, Pharmaceuticals CrossRef